EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrating genomics with the gut-brain axis: current evidence in autism spectrum disorder, epilepsy, schizophrenia, and emerging future challenges

Ericka C. Loza López, Gabriela Cano-Herrera, Maria F. Bautista Gonzalez, Amairani Méndez Vionet, Ximena A. Van Tienhoven, Emmanuel Simental Aldaba, Enrique de Jesús Guzmán Argüelles, Renata Murguiondo Pérez, Patricia Carolina Massieu Pérez, Diego De León Vela, Layra Mena García, Itzel Valeria Alpizar Andrade und 1 weitere

Exploration of Neuroprotective Therapy · 12.04.2026 · 6

DOI: 10.37349/ent.2026.1004146 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Exploration of Neuroprotective Therapy, online erschienen am 12.04.2026. Verfasst von Ericka C. Loza López und 12 weiteren Autor:innen. Die Arbeit nennt 206 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The relationship between the gut microbiota and the central nervous system has gained attention as a biological axis that may influence the development of several neurological disorders. Recent evidence integrating genomic, neurobiological, and microbiota research shows how bacterial composition, host genetic variability, and the mechanisms of the microbiota-gut-brain axis interact in conditions such as autism spectrum disorder, epilepsy, and schizophrenia. These interactions function through neural, metabolic, and immunological related pathways involving intestinal and blood-brain barrier permeability. Genome-wide association studies (GWAS) and Mendelian randomization analyses highlight shared immunogenetic pathways that may shape both microbial profiles and neurological susceptibility. Consistent patterns of dysbiosis and alterations in neuroactive metabolites have also been reported, linking microbiota changes to neuroinflammation and disrupted neuronal signaling. This review synthesizes the current evidence supporting the integration of the microbiota-gut-brain axis and its underlying communication pathways. It also outlines the present therapeutic strategies for neurological disorders such as autism spectrum disorder, epilepsy, and schizophrenia, highlighting their potential to modulate neurological function. Additionally, it discusses the existing limitations in the field and offers insights into future research directions within this rapidly evolving area.

Zitieren

APA

López, E. C. L., Cano-Herrera, G., Gonzalez, M. F. B., Vionet, A. M., Tienhoven, X. A. V., Aldaba, E. S., Argüelles, E. D. J. G., Pérez, R. M., Pérez, P. C. M., Vela, D. D. L., García, L. M., Andrade, I. V. A., & Salazar, F. E. (2026). Integrating genomics with the gut-brain axis: current evidence in autism spectrum disorder, epilepsy, schizophrenia, and emerging future challenges. Exploration of Neuroprotective Therapy, 6. https://doi.org/10.37349/ent.2026.1004146

Vancouver

López ECL, Cano-Herrera G, Gonzalez MFB, Vionet AM, Tienhoven XAV, Aldaba ES, et al. Integrating genomics with the gut-brain axis: current evidence in autism spectrum disorder, epilepsy, schizophrenia, and emerging future challenges. Exploration of Neuroprotective Therapy. 2026;6. doi:10.37349/ent.2026.1004146

BibTeX
@article{Lpez2026,
  author = {López, Ericka C. Loza and Cano-Herrera, Gabriela and Gonzalez, Maria F. Bautista and Vionet, Amairani Méndez and Tienhoven, Ximena A. Van and Aldaba, Emmanuel Simental and Argüelles, Enrique de Jesús Guzmán and Pérez, Renata Murguiondo and Pérez, Patricia Carolina Massieu and Vela, Diego De León and García, Layra Mena and Andrade, Itzel Valeria Alpizar and Salazar, Felipe Esparza},
  title = {Integrating genomics with the gut-brain axis: current evidence in autism spectrum disorder, epilepsy, schizophrenia, and emerging future challenges},
  journal = {Exploration of Neuroprotective Therapy},
  year = {2026},
  volume = {6},
  doi = {10.37349/ent.2026.1004146}
}
Kostenlos starten →